Name of Executive
EX-10.1 2 a19216exv10w1.htm EXHIBIT 10.1 Exhibit 10.1
EXHIBIT 10.1
SECOND AMENDMENT TO
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
THIS SECOND AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Amendment”) is entered into effective as of March 27, 2006, by and between CancerVax Corporation, a Delaware corporation (the “Company”), and David F. Hale (“Executive”).
WHEREAS, the Company and Executive desire to amend that certain Amended and Restated Employment Agreement dated as of November 15, 2004, between the Company and Executive (as amended to date, the “Original Agreement”) on the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the various covenants and agreements hereinafter set forth, the parties hereto agree as follows:
1. Amendment to Section 4(g)(vi). A new sentence is added at the end of Section 4(g)(vi) of the Original Agreement to read as follows:
“Notwithstanding the foregoing, none of the Stock Awards granted to Executive on March 20, 2006 shall accelerate pursuant to clauses (i), (ii), (iii), (iv) or (v) of this Section 4(g).”
2. No Other Amendments. Except as expressly provided for in this Amendment, no other term or provision of the Original Agreement is amended or modified in any respect.
(Signature Page Follows)
IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first set forth above.
| CANCERVAX CORPORATION | ||||
| By: | /s/ William R. LaRue | |||
| Name: | William R. LaRue | |||
| Title: | Senior Vice President and Chief Financial Officer | |||
| /s/ David F. Hale | ||||
| David F. Hale | ||||
[SIGNATURE PAGE TO SECOND AMENDMENT TO
AMENDED AND RESTATED EMPLOYMENT AGREEMENT]
AMENDED AND RESTATED EMPLOYMENT AGREEMENT]
